| Current challenges in cancer treatment J Zugazagoitia, C Guedes, S Ponce, I Ferrer, S Molina-Pinelo, L Paz-Ares Clinical therapeutics 38 (7), 1551-1566, 2016 | 1002 | 2016 |
| KRAS-Mutant non-small cell lung cancer: From biology to therapy I Ferrer, J Zugazagoitia, S Herbertz, W John, L Paz-Ares, ... Lung cancer 124, 53-64, 2018 | 336 | 2018 |
| RANK induces epithelial–mesenchymal transition and stemness in human mammary epithelial cells and promotes tumorigenesis and metastasis M Palafox, I Ferrer, P Pellegrini, S Vila, S Hernandez-Ortega, ... Cancer research 72 (11), 2879-2888, 2012 | 223 | 2012 |
| S-adenosylhomocysteine hydrolase downregulation contributes to tumorigenesis JF Leal, I Ferrer, C Blanco-Aparicio, J Hernandez-Losa, S Ramon y Cajal, ... Carcinogenesis 29 (11), 2089-2095, 2008 | 115 | 2008 |
| Epithelial-to-mesenchymal transition and stem cells in endometrial cancer C Mirantes, I Espinosa, I Ferrer, X Dolcet, J Prat, X Matias-Guiu Human pathology 44 (10), 1973-1981, 2013 | 105 | 2013 |
| MicroRNA-dependent regulation of transcription in non-small cell lung cancer S Molina-Pinelo, G Gutiérrez, MD Pastor, M Hergueta, G Moreno-Bueno, ... PloS one 9 (3), e90524, 2014 | 97 | 2014 |
| Resistance to taxanes in triple-negative breast cancer associates with the dynamics of a CD49f+ tumor-initiating population J Gómez-Miragaya, M Palafox, L Paré, G Yoldi, I Ferrer, S Vila, P Galván, ... Stem cell reports 8 (5), 1392-1407, 2017 | 86 | 2017 |
| PPP1CA contributes to the senescence program induced by oncogenic Ras ME Castro, I Ferrer, A Cascón, MV Guijarro, M Lleonart, SR Cajal, ... Carcinogenesis 29 (3), 491-499, 2008 | 73 | 2008 |
| YES1 drives lung cancer growth and progression and predicts sensitivity to dasatinib I Garmendia, MJ Pajares, F Hermida-Prado, D Ajona, C Bértolo, C Sainz, ... American journal of respiratory and critical care medicine 200 (7), 888-899, 2019 | 70 | 2019 |
| FGFR1 cooperates with EGFR in lung cancer oncogenesis, and their combined inhibition shows improved efficacy A Quintanal-Villalonga, S Molina-Pinelo, C Cirauqui, L Ojeda-Márquez, ... Journal of Thoracic Oncology 14 (4), 641-655, 2019 | 65 | 2019 |
| Antitumor activity of an engineered decoy receptor targeting CLCF1–CNTFR signaling in lung adenocarcinoma JW Kim, CP Marquez, K Kostyrko, AL Koehne, K Marini, DR Simpson, ... Nature medicine 25 (11), 1783-1795, 2019 | 64 | 2019 |
| Stratification of radiosensitive brain metastases based on an actionable S100A9/RAGE resistance mechanism C Monteiro, L Miarka, M Perea-García, N Priego, P García-Gómez, ... Nature medicine 28 (4), 752-765, 2022 | 61 | 2022 |
| Characterization of the p53 response to oncogene-induced senescence L Ruiz, M Traskine, I Ferrer, E Castro, JFM Leal, M Kaufman, A Carnero PloS one 3 (9), e3230, 2008 | 52 | 2008 |
| Impact of DLK1-DIO3 imprinted cluster hypomethylation in smoker patients with lung cancer S Molina-Pinelo, A Salinas, N Moreno-Mata, I Ferrer, R Suarez, ... Oncotarget 9 (4), 4395, 2016 | 51 | 2016 |
| Blood predictive biomarkers for patients with non–small-cell lung cancer associated with clinical response to Nivolumab MT Agulló-Ortuño, Ó Gómez-Martín, S Ponce, L Iglesias, L Ojeda, I Ferrer, ... Clinical lung cancer 21 (1), 75-85, 2020 | 50 | 2020 |
| Proteomic‐based approaches for the study of cytokines in lung cancer A Marrugal, L Ojeda, L Paz-Ares, S Molina-Pinelo, I Ferrer Disease markers 2016 (1), 2138627, 2016 | 50 | 2016 |
| Notch inhibition overcomes resistance to tyrosine kinase inhibitors in EGFR-driven lung adenocarcinoma EB Mur, S Bernardo, L Papon, M Mancini, E Fabbrizio, M Goussard, ... The Journal of clinical investigation 130 (2), 612-624, 2020 | 46 | 2020 |
| Targeting HER3, a catalytically defective receptor tyrosine kinase, prevents resistance of lung cancer to a third-generation EGFR kinase inhibitor D Romaniello, I Marrocco, N Belugali Nataraj, I Ferrer, D Drago-Garcia, ... Cancers 12 (9), 2394, 2020 | 42 | 2020 |
| The FOXO1-miR27 tandem regulates myometrial invasion in endometrioid endometrial adenocarcinoma A Mozos, L Catasús, E D’Angelo, E Serrano, I Espinosa, I Ferrer, C Pons, ... Human Pathology 45 (5), 942-951, 2014 | 35 | 2014 |
| The FGFR4-388arg variant promotes lung cancer progression by N-cadherin induction Á Quintanal-Villalonga, L Ojeda-Márquez, Á Marrugal, P Yagüe, ... Scientific reports 8 (1), 2394, 2018 | 34 | 2018 |
